IL111375A - N-substituted azabicycloalkane derivatives and pharmaceutical compositions containing them - Google Patents

N-substituted azabicycloalkane derivatives and pharmaceutical compositions containing them

Info

Publication number
IL111375A
IL111375A IL111375A IL11137594A IL111375A IL 111375 A IL111375 A IL 111375A IL 111375 A IL111375 A IL 111375A IL 11137594 A IL11137594 A IL 11137594A IL 111375 A IL111375 A IL 111375A
Authority
IL
Israel
Prior art keywords
group
atom
hydroxyl
amino
alkyl
Prior art date
Application number
IL111375A
Other languages
English (en)
Other versions
IL111375A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL111375A0 publication Critical patent/IL111375A0/xx
Publication of IL111375A publication Critical patent/IL111375A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IL111375A 1993-11-10 1994-10-24 N-substituted azabicycloalkane derivatives and pharmaceutical compositions containing them IL111375A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4338396A DE4338396A1 (de) 1993-11-10 1993-11-10 N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung

Publications (2)

Publication Number Publication Date
IL111375A0 IL111375A0 (en) 1994-12-29
IL111375A true IL111375A (en) 1997-06-10

Family

ID=6502267

Family Applications (1)

Application Number Title Priority Date Filing Date
IL111375A IL111375A (en) 1993-11-10 1994-10-24 N-substituted azabicycloalkane derivatives and pharmaceutical compositions containing them

Country Status (11)

Country Link
US (2) US5908844A (de)
EP (1) EP0728136A1 (de)
JP (1) JPH09505283A (de)
AU (1) AU681204B2 (de)
BR (1) BR9408029A (de)
CA (1) CA2175683A1 (de)
DE (1) DE4338396A1 (de)
FI (1) FI961977A0 (de)
HU (1) HUT74691A (de)
IL (1) IL111375A (de)
WO (1) WO1995013279A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI274750B (en) * 1999-01-12 2007-03-01 Abbott Gmbh & Co Kg Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same
US7963904B2 (en) * 2000-09-29 2011-06-21 Delisle Clarence A Method and device for treating body ailments
SE0100326D0 (sv) 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
ATE382623T1 (de) 2004-06-09 2008-01-15 Hoffmann La Roche Octahydropyrrolo(3,4-c)pyrrolderivate und deren verwendung als antivirale mitteln
US7665658B2 (en) 2005-06-07 2010-02-23 First Data Corporation Dynamic aggregation of payment transactions
EA200870404A1 (ru) 2006-04-03 2009-04-28 Глэксо Груп Лимитед Производные азабицикло[3.1.0.]гексила в качестве модуляторов рецепторов допамина d3
EP2007751B1 (de) 2006-04-03 2013-08-21 Glaxo Group Limited Azabicyclo[3.1.0]hexylderivate als modulatoren von dopamin-d3-rezeptoren
EP2010523A1 (de) * 2006-04-27 2009-01-07 Glaxo Group Limited Als modulatoren für dopamin-d3-rezeptoren geeignete spiroverbindungen
GB0719235D0 (en) * 2007-10-02 2007-11-14 Glaxo Group Ltd Novel compounds
EP3978497A4 (de) * 2019-05-30 2022-07-13 Shanghai Institute of Materia Medica, Chinese Academy of Sciences Kondensierte ringverbindung, herstellungsverfahren dafür und verwendung davon
CN118359619A (zh) * 2023-01-18 2024-07-19 苏州旺山旺水生物医药股份有限公司 一种抗抑郁化合物的盐、其制备方法、包含其的药物组合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155668A (en) * 1960-04-11 1964-11-03 Sterling Drug Inc 1-[3-, 2-, and 1-indolyl)-lower-alkyl]-tertiary amines and intermediates therefor
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
US4548938A (en) * 1981-07-15 1985-10-22 Janssen Pharmaceutica N.V. 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
US5532243A (en) * 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
HU9601245D0 (en) 1996-07-29
FI961977A (fi) 1996-05-09
IL111375A0 (en) 1994-12-29
DE4338396A1 (de) 1995-05-11
CA2175683A1 (en) 1995-05-18
BR9408029A (pt) 1996-12-17
HUT74691A (en) 1997-01-28
US6096755A (en) 2000-08-01
WO1995013279A1 (de) 1995-05-18
US5908844A (en) 1999-06-01
AU681204B2 (en) 1997-08-21
FI961977A0 (fi) 1996-05-09
AU8105494A (en) 1995-05-29
JPH09505283A (ja) 1997-05-27
EP0728136A1 (de) 1996-08-28

Similar Documents

Publication Publication Date Title
IL111375A (en) N-substituted azabicycloalkane derivatives and pharmaceutical compositions containing them
KR960701019A (ko) 신규의 4-아미노피리딘, 이것의 제조방법 및 이것을 함유하는 약제(new 4-aminopyridines, process for preparing the same and me-dicaments containing the same)
HUP9802679A2 (hu) Multidrog rezisztencia hatással rendelkező tetralinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
NZ221141A (en) Triazolopyridine and traizoloquinoline derivatives, pharmaceutical compositions
CA2179306A1 (en) Dopamine receptor ligands
MY131381A (en) Piperazine derivatives suitable for use as pharmaceuticals, in particular as 5-ht1a receptor binding agents.
GB1098140A (en) 2-amino-halogenobenzylamines
ES2068214T3 (es) Derivado de n2-(1-carboxi-3-fenilpropil)-l-lisina y procedimiento para producir lisinopril utilizando el compuesto.
DE69020661D1 (de) Azabicyclische Derivate mit Affinität am Muskarine Rezeptor.
ZA831477B (en) Substituted pyridines,processes for preparing these and pharmaceutical composition thereof
DK0555351T3 (da) Oxysulfonylcarbamater
IL69931A (en) N-(6-chloro-pyrazin-2-yl)-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxides,their preparation and pharmaceutical compositions containing them
NO920619L (no) Oxazinobenzazolforbindelser
ATE68496T1 (de) Trizyklische derivate, agonistn von cholinergetischen rezeptoren und diese enthaltende arzneimittel.
ES451293A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ATE356805T1 (de) Oxophenylcyclohexylpropanolaminderivate, deren herstellung und verwendung in therapeutika
GB1005028A (en) Novel 1:4-benzodioxan derivatives
DK0462150T3 (da) Aryloxyalkylaminer, deres fremstilling og lægemidler indeholdende dem
IL107915A (en) N-substituted azabicycloheptane derivatives and their use as medicaments
UA41868C2 (uk) N-заміщені похідні 3-азабіцикло[3.2.0]гептану
HU894471D0 (en) Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them
IL113677A (en) Diamines and aminoamides and their preparation for use as intermediates for the preparation of 4, 5-dihydro-1h-2,4-aryl fused diazepines and benzodiazocines
ECSP920822A (es) Composiciones heterocyclicas
ES8600206A1 (es) Procedimiento de preparacion de derivados alquilenodiaminos

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void